204 related articles for article (PubMed ID: 15857538)
21. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
Tonkic A; Jukic I; Titlic M; Mise S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725
[No Abstract] [Full Text] [Related]
23. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
Tanchev S; Platikanov V; Karadimov D
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
[No Abstract] [Full Text] [Related]
24. Recombinant activated factor VII following pediatric cardiac surgery.
Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
[TBL] [Abstract][Full Text] [Related]
25. Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion.
Yadav SP; Sachdeva A; Bhat S; Katewa S
Pediatr Hematol Oncol; 2010 Feb; 27(1):24-30. PubMed ID: 20121552
[TBL] [Abstract][Full Text] [Related]
26. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
Khan AZ; Parry JM; Crowley WF; McAllen K; Davis AT; Bonnell BW; Hoogeboom JE
Am J Surg; 2005 Mar; 189(3):331-4. PubMed ID: 15792762
[TBL] [Abstract][Full Text] [Related]
27. Recombinant factor VIIa for severe gastrointestinal hemorrhage associated with Crohn disease.
Filik L
South Med J; 2007 Jun; 100(6):559. PubMed ID: 17591308
[No Abstract] [Full Text] [Related]
28. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
[TBL] [Abstract][Full Text] [Related]
29. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
30. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.
Girisch M; Rauch R; Carbon R; Habash T; Hofbeck M
Eur J Pediatr; 2004 Feb; 163(2):118-9. PubMed ID: 14716558
[No Abstract] [Full Text] [Related]
31. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
Al-Ruzzeh S; Navia JL
Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
[No Abstract] [Full Text] [Related]
32. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
33. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
34. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
35. Recombinant activated factor VII in paediatric cardiac surgery.
Egan JR; Lammi A; Schell DN; Gillis J; Nunn GR
Intensive Care Med; 2004 Apr; 30(4):682-5. PubMed ID: 14685661
[TBL] [Abstract][Full Text] [Related]
36. Recombinant factor VIIa and the surgical patient.
Scarpelini S; Rizoli S
Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
[TBL] [Abstract][Full Text] [Related]
37. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Franchini M; Manzato F; Salvagno GL; Lippi G
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
[TBL] [Abstract][Full Text] [Related]
38. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
39. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
40. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]